Complete financial analysis of TAUNS LABORATORIES INC. (197A.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TAUNS LABORATORIES INC., a leading company in the Medical – Specialties industry within the Healthcare sector.
You may be interested
- Nanjing Inform Storage Equipment (Group) Co., Ltd. (603066.SS) Income Statement Analysis – Financial Results
- Nevada Lithium Resources Inc. (NVLH.CN) Income Statement Analysis – Financial Results
- Starbreeze AB (publ) (0RUU.L) Income Statement Analysis – Financial Results
- TPG Pace Tech Opportunities Corp. (PACE-UN) Income Statement Analysis – Financial Results
- Jiangxi Xinyu Guoke Technology Co., Ltd (300722.SZ) Income Statement Analysis – Financial Results
TAUNS LABORATORIES INC. (197A.T)
About TAUNS LABORATORIES INC.
TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 18.43B | 15.67B | 17.46B |
| Cost of Revenue | 6.36B | 6.89B | 3.17B |
| Gross Profit | 12.07B | 8.79B | 14.29B |
| Gross Profit Ratio | 65.50% | 56.06% | 81.84% |
| Research & Development | 1.00B | 723.37M | 776.31M |
| General & Administrative | 27.99M | 1.74B | 1.56B |
| Selling & Marketing | 3.02B | 953.24M | 252.64M |
| SG&A | 3.04B | 3.10B | 2.32B |
| Other Expenses | 0.00 | 518.00K | 27.72M |
| Operating Expenses | 4.04B | 3.82B | 3.10B |
| Cost & Expenses | 10.40B | 10.71B | 6.27B |
| Interest Income | 2.34M | 3.97M | 35.00K |
| Interest Expense | 31.21M | 21.81M | 8.38M |
| Depreciation & Amortization | 676.16M | 639.97M | 567.24M |
| EBITDA | 8.71B | 5.61B | 8.55B |
| EBITDA Ratio | 47.23% | 35.78% | 67.35% |
| Operating Income | 8.03B | 4.97B | 11.19B |
| Operating Income Ratio | 43.56% | 31.69% | 64.10% |
| Total Other Income/Expenses | -195.40M | -312.42M | -3.21B |
| Income Before Tax | 7.83B | 4.65B | 7.98B |
| Income Before Tax Ratio | 42.50% | 29.70% | 45.69% |
| Income Tax Expense | 2.06B | 1.62B | 3.49B |
| Net Income | 5.77B | 3.03B | 4.48B |
| Net Income Ratio | 31.32% | 19.36% | 25.67% |
| EPS | 53.99 | 30.35 | 44.81 |
| EPS Diluted | 57.74 | 30.35 | 44.81 |
| Weighted Avg Shares Out | 106.95M | 100.00M | 100.00M |
| Weighted Avg Shares Out (Dil) | 100.00M | 100.00M | 100.00M |
No news found for: 197A.T
Source: https://incomestatements.info
Category: Stock Reports